Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 51.39% is 85% below its 5-year average of 349.89%, near the low end of its 5-year range (0.00%–1242.91%).
As of the fiscal period ended Tuesday, June 30, 2026. 45.74% above its 12-month average of 35.26%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 51.39%.
DEBT TO ASSETS RATIO
51.39%
DEBT TO ASSETS RATIO AVG TTM
35.26%
DEBT TO ASSETS RATIO AVG 3Y
346.00%
DEBT TO ASSETS RATIO AVG 5Y
349.89%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+45.74%
CURRENT VS 3Y AVG
-85.15%
CURRENT VS 5Y AVG
-85.31%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 809 covered companies
CURRENT VS SECTOR MEDIAN
+57003.29%
vs the sector median at left
OneMedNet Corporation
Market Cap
$29.53M
Debt to Assets Ratio
51.39%
TTM Avg
35.26%
3Y Avg
346.00%
5Y Avg
349.89%
Market Cap
$29.50M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$29.81M
Debt to Assets Ratio
0.04%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$27.74M
Debt to Assets Ratio
0.56%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OneMedNet Corporation (ONMD) | $29.53M | 51.39% | 35.26% | 346.00% | 349.89% |
| Context Therapeutics Inc. (CNTX)vs › | $29.50M | 0.01% | N/A | N/A | N/A |
| Quantum Cyber N.V. (QUCY)vs › | $29.55M | 0.01% | N/A | N/A | N/A |
| GridAI Technologies Corp. (GRDX)vs › | $29.81M | 0.04% | N/A | N/A | N/A |
| CervoMed Inc. (CRVO)vs › | $30.09M | 0.00% | N/A | N/A | N/A |
| BeyondSpring Inc. (BYSI)vs › | $30.34M | 0.01% | N/A | N/A | N/A |
| aTyr Pharma, Inc. (ATYR)vs › | $28.22M | 0.16% | N/A | N/A | N/A |
| MDxHealth S.A. (MDXH)vs › | $30.59M | 0.80% | N/A | N/A | N/A |
| Seres Therapeutics, Inc. (MCRB)vs › | $27.74M | 0.56% | N/A | N/A | N/A |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $31.12M | 0.00% | N/A | N/A | N/A |
Debt/Assets
51.4%
Debt/Equity
N/A
Current Ratio
0.28
Interest Coverage
-144.3x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 51.39% |
| 2026-03-31 | 55.54% |
| 2025-12-31 | 26.50% |
| 2025-09-30 | 25.76% |
| 2025-06-30 | 17.12% |
| 2025-03-31 | 434.12% |
| 2024-12-31 | 235.12% |
| 2024-09-30 | 200.59% |
| 2024-06-30 | 934.39% |
| 2024-03-31 | 906.27% |
| 2023-12-31 | 1101.66% |
| 2023-09-30 | 497.40% |
| 2023-06-30 | 12.18% |
| 2023-03-31 | 702.27% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 1242.91% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 554.54% |
| 2021-09-30 | 0.00% |
